Related Experiment Videos
In vitro gene transfer using human papillomavirus-like particles
1Institut de Virologie de Tours and CJF INSERM d'Immunologie des Maladies Infectieuses, Faculté des Sciences Pharmaceutiques 'Philippe Maupas', 31 avenue Monge, 37200 Tours, France.
Nucleic Acids Research
|April 4, 1998
Summary
Human papillomavirus-like particles (VLPs) can package and deliver foreign DNA to cells, showing promise for gene therapy applications. This novel gene delivery method using VLPs is efficient and easier to prepare than current options.
Area of Science:
- Virology
- Molecular Biology
- Gene Therapy
Background:
- Recombinant papillomavirus-like particles (VLPs) are effective for preventing papillomavirus infections and associated tumors.
- VLPs offer potential applications in gene therapy and DNA immunization beyond vaccine development.
Purpose of the Study:
- To investigate the potential of human papillomavirus-like particles (VLPs) as a vehicle for gene delivery.
- To evaluate the efficiency of VLP-mediated gene transfer into eukaryotic cells.
Main Methods:
- Human papillomavirus-like particles (VLPs) composed of HPV-16 L1 protein were generated.
- VLPs were used to package unrelated plasmid DNA in vitro.
- Gene transfer efficiency into eukaryotic cells was assessed, comparing VLP delivery to DNA alone or liposome delivery.
Main Results:
- Human papillomavirus-like particles (VLPs) successfully packaged plasmid DNA.
- VLPs efficiently delivered foreign DNA into eukaryotic cells, leading to expression of the encoded gene.
- VLP-mediated gene transfer demonstrated higher efficiency compared to DNA alone or liposome-mediated delivery.
Conclusions:
- Virus-like particles (VLPs) are a promising and effective vehicle for delivering genetic material to target cells.
- VLP-based gene transfer offers advantages over existing methods, with relatively easy preparation of the delivery vehicle.